Asarina Pharma AB (publ) (STO:ASAP)

Asarina Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.16	13.58	21.72	58.5	129.51
Cash & Short-Term Investments	3.16	13.58	21.72	58.5	129.51
Cash Growth	-76.72%	-37.48%	-62.88%	-54.83%	-8.50%
Other Receivables	2.14	2.05	7.13	7.87	8.62
Receivables	2.14	2.05	7.13	7.87	8.62
Prepaid Expenses	-	0.04	0.04	0.08	-
Other Current Assets	-0	-	-	-	-
Total Current Assets	5.3	15.68	28.88	66.45	138.13
Property, Plant & Equipment	0.78	1.18	1.48	1.83	1.77
Long-Term Investments	0	0	0	0	0
Other Long-Term Assets	0	-	-	-	-
Total Assets	6.08	16.86	30.36	68.29	139.89
Accounts Payable	0.63	0.84	2.15	11.31	16.61
Accrued Expenses	1.6	1.01	1.09	4.27	2.99
Short-Term Debt	1	-	-	-	-
Current Portion of Long-Term Debt	-	-	5.3	-	-
Other Current Liabilities	1.2	0.41	0.68	0.11	0.82
Total Current Liabilities	4.43	2.26	9.22	15.69	20.42
Other Long-Term Liabilities	0	-0	-	-	-
Total Liabilities	4.43	2.25	9.22	15.69	20.42
Common Stock	5.66	5.66	4.69	4.69	4.61
Additional Paid-In Capital	277.68	277.68	272.81	272.81	264.5
Retained Earnings	-281.69	-268.74	-256.36	-224.9	-149.64
Comprehensive Income & Other	0	0	-	-	-
Shareholders' Equity	1.65	14.6	21.14	52.6	119.47
Total Liabilities & Equity	6.08	16.86	30.36	68.29	139.89
Total Debt	1	-	5.3	-	-
Net Cash (Debt)	2.16	13.58	16.42	58.5	129.51
Net Cash Growth	-84.08%	-17.29%	-71.94%	-54.83%	-8.50%
Net Cash Per Share	0.10	0.72	0.88	3.13	7.83
Filing Date Shares Outstanding	22.64	22.64	18.74	18.74	18.74
Total Common Shares Outstanding	22.64	22.64	18.74	18.74	18.44
Working Capital	0.87	13.42	19.67	50.77	117.7
Book Value Per Share	0.07	0.64	1.13	2.81	6.48
Tangible Book Value	1.65	14.6	21.14	52.6	119.47
Tangible Book Value Per Share	0.07	0.64	1.13	2.81	6.48
Machinery	2.13	2.1	1.95	1.92	1.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.